Evaluating SGLT2 Inhibitors for the Reduction of No-Reflow Phenomenon in Patients Undergoing PCI (clinicaltrials.gov) - Oct 28, 2026 - P2 | N=100 | Not yet recruiting | Sponsor: Al-Azhar University
New P2 trial • Cardiovascular • Coronary Artery Disease • Myocardial Infarction • Reperfusion Injury
|